Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Statistical analyses

AR Aleksandra Rajewska-Rager
MD Monika Dmitrzak-Weglarz
PK Pawel Kapelski
NL Natalia Lepczynska
JP Joanna Pawlak
JT Joanna Twarowska-Hauser
MS Maria Skibinska
request Request a Protocol
ask Ask a question
Favorite

The Kolmogorov-Smirnoff test was used to check the normality of the data. S100B levels showed non-normal distribution, thus nonparametric methods were used. The U-Mann–Whitney test, Kruskal–Wallis Anova, and paired Wilcoxon signed rank test were applied in the analyses. Linear regression was used in S100B x symptoms severity, and in gender analyses. Spearman’s rank correlation between S100B baseline levels and clinical variables was performed. The significance level after Bonferroni correction for multiple testing was set at p < 0.007. The statistical analyses were performed using the R project23 and Statistica v13 software24.

Copyright and License information: The Author(s) ©2021
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A